| Dr Virginia Yahui Li, MD | |
|
101 Manning Dr, Chapel Hill, NC 27514-4220 | |
| (984) 974-1000 | |
| Not Available |
| Full Name | Dr Virginia Yahui Li |
|---|---|
| Gender | Female |
| Speciality | Student In An Organized Health Care Education/training Program |
| Location | 101 Manning Dr, Chapel Hill, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790131381 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 2022-01872 (North Carolina) | Secondary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
Corindus Vascular Robotics, a leading developer of precision vascular robotics, today announced that Giora Weisz, M.D., Director of Clinical Cardiovascular Research at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center and Associate Professor of medicine at Columbia University College of Physicians and Surgeons, New York, N.Y. will present his personal experience using the CorPath 200 System as part of the CorPath PRECISE Trial during a scientific presentation "Cath Lab of the Future: Robotics" at the Cardiovascular Research Technologies' annual meeting, CRT2012.
In the largest ever assessment of substance use among people with severe psychiatric illness, researchers at Washington University School of Medicine in St. Louis and the University of Southern California have found that rates of smoking, drinking and drug use are significantly higher among those who have psychotic disorders than among those in the general population.
"A committee of the International Commission on Non-Ionizing Radiation Protection has concluded after a comprehensive review that there is little cause for concern about the suggested link between mobile phone use and brain tumours," BMJ reports.
American pharmaceutical manufacturer Alpharma Inc. has agreed to pay $42.5 million to resolve False Claims Act allegations in connection with the marketing of the morphine-based drug, Kadian, the Justice Department announced today. The settlement resolves allegations that, between January 1, 2000 and December 29, 2008, Alpharma paid health care providers to induce them to promote or prescribe Kadian, and made misrepresentations about the safety and efficacy of the drug, which is used to treat chronic moderate to severe pain.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Virginia Yahui Li, MD 7161 Grayson Dr, Canfield, OH 44406-7638 Ph: (330) 519-8226 | Dr Virginia Yahui Li, MD 101 Manning Dr, Chapel Hill, NC 27514-4220 Ph: (984) 974-1000 |
News Archive
Corindus Vascular Robotics, a leading developer of precision vascular robotics, today announced that Giora Weisz, M.D., Director of Clinical Cardiovascular Research at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center and Associate Professor of medicine at Columbia University College of Physicians and Surgeons, New York, N.Y. will present his personal experience using the CorPath 200 System as part of the CorPath PRECISE Trial during a scientific presentation "Cath Lab of the Future: Robotics" at the Cardiovascular Research Technologies' annual meeting, CRT2012.
In the largest ever assessment of substance use among people with severe psychiatric illness, researchers at Washington University School of Medicine in St. Louis and the University of Southern California have found that rates of smoking, drinking and drug use are significantly higher among those who have psychotic disorders than among those in the general population.
"A committee of the International Commission on Non-Ionizing Radiation Protection has concluded after a comprehensive review that there is little cause for concern about the suggested link between mobile phone use and brain tumours," BMJ reports.
American pharmaceutical manufacturer Alpharma Inc. has agreed to pay $42.5 million to resolve False Claims Act allegations in connection with the marketing of the morphine-based drug, Kadian, the Justice Department announced today. The settlement resolves allegations that, between January 1, 2000 and December 29, 2008, Alpharma paid health care providers to induce them to promote or prescribe Kadian, and made misrepresentations about the safety and efficacy of the drug, which is used to treat chronic moderate to severe pain.
› Verified 6 days ago